{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:12:40Z","timestamp":1777648360512,"version":"3.51.4"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["Number-37\/1746\/23\/EMR-II"],"award-info":[{"award-number":["Number-37\/1746\/23\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116199","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T04:21:55Z","timestamp":1712636515000},"page":"116199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Potential small effector molecules restoring cellular defects due to sialic acid biosynthetic enzyme deficiency: Pathological relevance to GNE myopathy"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3154-3484","authenticated-orcid":false,"given":"Fluencephila","family":"Mashangva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti","family":"Oswalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0843-385X","authenticated-orcid":false,"given":"Shagun","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-9351","authenticated-orcid":false,"given":"Ranjana","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2024.116199_b0005","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.1002310","article-title":"GNE myopathy: History, etiology, and treatment trials","volume":"13","author":"Mullen","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bcp.2024.116199_b0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-018-0802-x","article-title":"GNE myopathy: From clinics and genetics to pathology and research strategies","volume":"13","author":"Pogoryelova","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bcp.2024.116199_b0015","doi-asserted-by":"crossref","unstructured":"N. Carrillo, M.C. Malicdan, M. Huizing, GNE Myopathy: Etiology, Diagnosis, and Therapeutic Challenges, 000 (2018) 900\u2013914.","DOI":"10.1007\/s13311-018-0671-y"},{"key":"10.1016\/j.bcp.2024.116199_b0020","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006932","article-title":"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy","author":"Lochm\u00fcller","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2024.116199_b0025","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41436-021-01259-x","article-title":"Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: An open-label phase 2 study","volume":"23","author":"Carrillo","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.bcp.2024.116199_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2017.04.010","article-title":"Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy","author":"Xu","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2024.116199_b0035","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.nmd.2012.03.013","article-title":"Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery","volume":"22","author":"Mitrani-Rosenbaum","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bcp.2024.116199_b0040","doi-asserted-by":"crossref","unstructured":"I. Dosing, G. Lipoplex, G. Nemunaitis, C.M. Jay, P.B. Maples, W.A. Gahl, M. Huizing, T. Yardeni, A.W. Tong, A.P. Phadke, B.O. Pappen, C. Bedell, H. Allen, C. Hernandez, N.S. Templeton, J. Kuhn, N. Senzer, Hereditary Inclusion Body Myopathy: Single Patient, 1341 (2011) 1331\u20131341. https:\/\/doi.org\/10.1089\/hum.2010.192.","DOI":"10.1089\/hum.2010.192"},{"key":"10.1016\/j.bcp.2024.116199_b0045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JND-210755","article-title":"Pre clinical assessment of AAVrh74.MCK.GNE viral vector therapeutic potential: Robust activity despite lack of consistent animal model for GNE myopathy","volume":"9","author":"Mitrani-Rosenbaum","year":"2022","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.bcp.2024.116199_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2377-7-3","article-title":"Intravenous immune globulin in hereditary inclusion body myopathy: A pilot study","volume":"7","author":"Sparks","year":"2007","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bcp.2024.116199_b0055","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/brain\/awu210","article-title":"Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice","volume":"137","author":"Yonekawa","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2024.116199_b0060","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddm220","article-title":"A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2024.116199_b0065","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ymgme.2012.10.011","article-title":"Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy","volume":"107","author":"Niethamer","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bcp.2024.116199_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0173261","article-title":"Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116199_b0075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.072066199","article-title":"Sialylation is essential for early development in mice","author":"Schwarzkopf","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2024.116199_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2022.976111","article-title":"Generation and characterization of a novel gne Knockout Model in Zebrafish","volume":"10","author":"Livne","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2024.116199_b0085","unstructured":"R.E. Schmitt, D.Y.S. Iv, D.S. Cho, Z. Niu, M. Milone, J.D. Doles, Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy, (n.d.)."},{"key":"10.1016\/j.bcp.2024.116199_b0090","doi-asserted-by":"crossref","unstructured":"S.S. Devi, R. Yadav, R. Arya, Altered Actin Dynamics in Cell Migration of GNE Mutant Cells, 9 (2021) 1\u201318. https:\/\/doi.org\/10.3389\/fcell.2021.603742.","DOI":"10.3389\/fcell.2021.603742"},{"key":"10.1016\/j.bcp.2024.116199_b0095","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12017-022-08711-4","article-title":"Effect of GNE mutations on cytoskeletal network proteins: potential gateway to understand pathomechanism of GNEM","volume":"24","author":"Yadav","year":"2022","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bcp.2024.116199_b0100","doi-asserted-by":"crossref","first-page":"35777599","DOI":"10.1016\/j.biocel.2022.106258","article-title":"Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: Therapeutic lead for GNE Myopathy","volume":"149","author":"Yadav","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116199_b0105","first-page":"1","article-title":"Elucidation of ER stress and UPR pathway in sialic acid-deficient cells: Pathological relevance to GNEM","author":"Chaudhary","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116199_b0110","article-title":"Role of IGF-1R in ameliorating apoptosis of GNE deficient cells","author":"Singh","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116199_b0115","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1007\/s12035-021-02549-w","article-title":"Generation and characterization of a skeletal muscle cell-based model carrying one single GNE allele: Implications in actin dynamics","volume":"58","author":"Devi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2024.116199_b0120","doi-asserted-by":"crossref","unstructured":"S. Amsili, H. Zer, S. Hinderlich, S. Krause, M. Becker-cohen, G. Daniel, K.N. North, S. Mitrani-rosenbaum, Acetylmannosamine Kinase (GNE) Binds to Alpha-Actinin 1: Novel Pathways in Skeletal Muscle\u00a0?, 3 (2008) 1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0002477.","DOI":"10.1371\/journal.pone.0002477"},{"key":"10.1016\/j.bcp.2024.116199_b0125","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.febslet.2006.11.015","article-title":"The collapsin response mediator protein 1 (CRMP-1) and the promyelocytic leukemia zinc finger protein (PLZF) bind to UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis","volume":"580","author":"Weidemann","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2024.116199_b0130","doi-asserted-by":"crossref","first-page":"e16334","DOI":"10.1371\/journal.pone.0016334","article-title":"The proteomic profile of hereditary inclusion body myopathy","volume":"6","author":"Sela","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116199_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.603742","article-title":"Altered actin dynamics in cell migration of GNE mutant cells","volume":"9","author":"Devi","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2024.116199_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgeed.2022.930110","article-title":"In vivo and in vitro genome editing to explore GNE functions","volume":"4","author":"Ilouz","year":"2022","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.bcp.2024.116199_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-013-8604-6","article-title":"Role of UDP-N-acetylglucosamine2-epimerase\/N-acetylmannosamine kinase (GNE) in \u03b21-integrin-mediated cell adhesion","author":"Grover","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2024.116199_b0150","doi-asserted-by":"crossref","first-page":"12683","DOI":"10.1074\/jbc.M411494200","article-title":"Calcium signal-induced cofilin dephosphorylation is mediated by slingshot via calcineurin","volume":"280","author":"Wang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116199_b0155","doi-asserted-by":"crossref","unstructured":"A. E, L. CY, Neuroprotective Effect of Chlorogenic Acids against Alzheimer\u2019s Disease, Int. J. Food Sci. Nutr. Diet. 6 (2017) 330\u2013337. https:\/\/doi.org\/10.19070\/2326-3350-1700059.","DOI":"10.19070\/2326-3350-1700059"},{"key":"10.1016\/j.bcp.2024.116199_b0160","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s00394-017-1379-1","article-title":"The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: A comprehensive review of the literature","volume":"56","author":"Tajik","year":"2017","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bcp.2024.116199_b0165","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1001\/archinternmed.2009.439","article-title":"Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis","volume":"169","author":"Huxley","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bcp.2024.116199_b0170","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1016\/j.bmc.2012.08.001","article-title":"Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid \u03b2-protein","volume":"20","author":"Miyamae","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bcp.2024.116199_b0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2019.05.001","article-title":"Coffee polyphenols prevent cognitive dysfunction and suppress amyloid \u03b2 plaques in APP\/PS2 transgenic mouse","volume":"154","author":"Ishida","year":"2020","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bcp.2024.116199_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2016.02.019","article-title":"Protective effects of a Chotosan fraction and its active components on \u03b2-amyloid-induced neurotoxicity","volume":"617","author":"Wei","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2024.116199_b0185","unstructured":"L. Wan, Ruiqian, Weigand, \u57fa\u56e0\u7684\u6539\u53d8NIH Public Access, J Neurochem. 4 (2015) 1\u201315. https:\/\/doi.org\/10.3233\/JAD-2009-0969.Grape."},{"key":"10.1016\/j.bcp.2024.116199_b0190","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12017-017-8467-5","article-title":"Mutation in GNE downregulates peroxiredoxin IV altering ER Redox Homeostasis","volume":"19","author":"Chanana","year":"2017","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bcp.2024.116199_b0195","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jcb.30148","article-title":"Elucidation of ER stress and UPR pathway in sialic acid-deficient cells: Pathological relevance to GNEM","volume":"122","author":"Chaudhary","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2024.116199_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106258","article-title":"Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: Therapeutic lead for GNE Myopathy","volume":"149","author":"Yadav","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116199_b0205","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1152\/physiolgenomics.90219.2008","article-title":"Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV\/hIBM","volume":"35","author":"Malicdan","year":"2008","journal-title":"Physiol. Genom."},{"key":"10.1016\/j.bcp.2024.116199_b0210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25020429","article-title":"Pharmacological overview of the BGP-15 chemical agent as a new drug candidate for the treatment of symptoms of metabolic syndrome","volume":"25","author":"Pet\u0151","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2024.116199_b0215","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1055\/s-0028-1128142","article-title":"Improvement of insulin sensitivity by a novel drug, BGP-15, in insulin-resistant patients: a proof of concept randomized double-blind clinical trial","volume":"41","author":"Liter\u00e1ti-Nagy","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.bcp.2024.116199_b0220","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1016\/j.ajpath.2016.08.008","article-title":"BGP-15 improves aspects of the dystrophic pathology in mdx and dko mice with differing efficacies in heart and skeletal muscle","volume":"186","author":"Kennedy","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2024.116199_b0225","article-title":"Inducible heat shock protein 70 levels in patients and the mdx mouse affirm regulation during skeletal muscle regeneration in muscular dystrophy","volume":"14","author":"Cosemans","year":"2022","journal-title":"Front. Biosci. - Sch."},{"key":"10.1016\/j.bcp.2024.116199_b0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0041-008X(03)00155-8","article-title":"BGP-15, a hydroximic acid derivative, protects against cisplatin- or taxol-induced peripheral neuropathy in rats","volume":"190","author":"B\u00e1rdos","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116199_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/apha.13425","article-title":"Chaperone co-inducer BGP-15 mitigates early contractile dysfunction of the soleus muscle in a rat ICU model","volume":"229","author":"Cacciani","year":"2020","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bcp.2024.116199_b0240","doi-asserted-by":"crossref","first-page":"350ra103","DOI":"10.1126\/scitranslmed.aaf7099","article-title":"The chaperone co-inducer BGP-15 alleviates ventilation-induced diaphragm dysfunction","volume":"8","author":"Salah","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bcp.2024.116199_b0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-022-00714-7","article-title":"Critical illness myopathy: Diagnostic approach and resulting therapeutic implications","volume":"24","author":"Rodriguez","year":"2022","journal-title":"Curr. Treat. Options Neurol."},{"key":"10.1016\/j.bcp.2024.116199_b0250","first-page":"29","article-title":"The role of Igf-1 on muscle wasting: a therapeutic approach","volume":"14","author":"Musar\u00f2","year":"2004","journal-title":"Basic Appl. Myol."},{"key":"10.1016\/j.bcp.2024.116199_b0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000207474","article-title":"Muscle involvement and IGF-1 signaling in genetic disorders: New therapeutic approaches","volume":"14","author":"Barberi","year":"2009","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.bcp.2024.116199_b0260","first-page":"1","article-title":"Identification of the molecular mechanism of insulin - like growth factor - 1 (IGF - 1): A promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome","author":"Arjunan","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bcp.2024.116199_b0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacbts.2022.12.006","article-title":"IGF-1 therapy improves muscle size and function in experimental peripheral arterial disease","volume":"8","author":"Dong","year":"2023","journal-title":"JACC Basic to Transl. Sci."},{"key":"10.1016\/j.bcp.2024.116199_b0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pep.2004.02.013","article-title":"UDP-N-acetylglucosamine2-epimerase\/N-acetylmannosamine kinase, functionally expressed in and purified from Escherichia coli, yeast, and insect cells","volume":"35","author":"Blume","year":"2004","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bcp.2024.116199_b0275","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biochi.2022.03.014","article-title":"Functional characterization of GNE mutations prevalent in Asian subjects with GNE myopathy, an ultra-rare neuromuscular disorder","volume":"199","author":"Sharma","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.bcp.2024.116199_b0280","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0021-9258(18)65959-9","article-title":"A modified estimation","author":"Reissig","year":"1955","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116199_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2007.07.060","article-title":"Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase\/ManAc kinase containing a sialuria mutation in CHO cells","author":"Bork","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2024.116199_b0290","doi-asserted-by":"crossref","unstructured":"A. Di Turi, M. Antonacci, J.R. Dibenedetto, F. Maqoud, F. Leonetti, G. Centoducati, N. Colonna, D. Tricarico, Molecular Composition and Biological Activity of a Novel Acetonitrile \u2013 Water Extract of Lens Culinaris Medik in Murine Native Cells and Cell Lines Exposed to Different Chemotherapeutics Using Mass Spectrometry, (2023).","DOI":"10.3390\/cells12040575"},{"key":"10.1016\/j.bcp.2024.116199_b0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature08908","article-title":"Cell mechanics and the cytoskeleton","volume":"463","author":"Fletcher","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2024.116199_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016334","article-title":"The proteomic profile of hereditary inclusion body myopathy","author":"Sela","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116199_b0305","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/labinvest.2013.112","article-title":"Establishment of a system for monitoring endoplasmic reticulum redox state in mammalian cells","volume":"93","author":"Kanekura","year":"2013","journal-title":"Lab. Investig."},{"key":"10.1016\/j.bcp.2024.116199_b0310","doi-asserted-by":"crossref","unstructured":"A. Cho, M. Christine, V. Malicdan, M. Miyakawa, I. Nonaka, I. Nishino, S. Noguchi, Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy, 26 (2017) 3081\u20133093. https:\/\/doi.org\/10.1093\/hmg\/ddx192.","DOI":"10.1093\/hmg\/ddx192"},{"key":"10.1016\/j.bcp.2024.116199_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002477","article-title":"UDP-N-acetylglucosamine-2-epimerase\/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: Novel pathways in skeletal muscle?","volume":"3","author":"Amsili","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116199_b0320","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1007\/s12035-016-9862-x","article-title":"The interaction of UDP-N-Acetylglucosamine 2-Epimerase\/N-acetylmannosamine kinase (GNE) and alpha-actinin 2 is altered in GNE myopathy M743T mutant","volume":"54","author":"Harazi","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2024.116199_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2023.08.013","article-title":"GNE myopathy: Can homozygous asymptomatic subjects give a clue for the identification of protective factors?","author":"Mitrani-Rosenbaum","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bcp.2024.116199_b0330","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12035-013-8604-6","article-title":"Role of UDP-N-Acetylglucosamine2-Epimerase\/N-acetylmannosamine kinase (GNE) in \u03b21-integrin-mediated cell adhesion","volume":"50","author":"Grover","year":"2014","journal-title":"Mol. Neurobiol."},{"issue":"29","key":"10.1016\/j.bcp.2024.116199_b0335","first-page":"1","article-title":"Understanding pathophysiology of GNE myopathy and current progress towards drug development","volume":"49","author":"Mashangva","year":"2024","journal-title":"J. Biosci."},{"key":"10.1016\/j.bcp.2024.116199_b0340","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","article-title":"Chlorogenic acid (CGA): A pharmacological review and call for further research","volume":"97","author":"Naveed","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116199_b0345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874467212666190716145210","article-title":"Therapeutic promises of chlorogenic acid with special emphasis on its anti-obesity property","volume":"13","author":"Kumar","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116199_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106505","article-title":"Chlorogenic acid for cancer prevention and therapy: Current status on efficacy and mechanisms of action","volume":"186","author":"Gupta","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2024.116199_b0355","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/1028415X.2021.2009993","article-title":"Chlorogenic acid delays the progression of Parkinson\u2019s disease via autophagy induction in Caenorhabditis elegans","volume":"26","author":"He","year":"2023","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bcp.2024.116199_b0360","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/ajcn\/nqaa312","article-title":"Acute dose-response effect of coffee-derived chlorogenic acids on the human vasculature in healthy volunteers: A randomized controlled trial","volume":"113","author":"Naylor","year":"2021","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.bcp.2024.116199_b0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/jhh.2014.46","article-title":"The effect of chlorogenic acid on blood pressure: A systematic review and meta-analysis of randomized clinical trials","volume":"29","author":"Onakpoya","year":"2015","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.bcp.2024.116199_b0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/nu10101337","article-title":"Effect of chlorogenic acids on cognitive function: A randomized, double-blind, placebo-controlled trial","volume":"10","author":"Saitou","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2024.116199_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081020","article-title":"Neuroprotective effects of chlorogenic acid in a mouse model of intracerebral hemorrhage associated with reduced extracellular matrix metalloproteinase inducer","volume":"12","author":"Liu","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2024.116199_b0380","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbpa.2021.05.006","article-title":"ScienceDirect Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?","volume":"64","author":"Lashuel","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bcp.2024.116199_b0385","doi-asserted-by":"crossref","unstructured":"L. Xiang, Y. Wang, S. Liu, B. Liu, X. Jin, X. Cao, Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases, (2023).","DOI":"10.3390\/ijms241411275"},{"issue":"Suppl","key":"10.1016\/j.bcp.2024.116199_b0390","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2024.116199_b0395","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2018.00669","article-title":"Fighting the cause of Alzheimer\u2019s and GNE myopathy","author":"Devi","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2024.116199_b0400","article-title":"Unfolded protein response and activated degradative pathways regulation in GNE myopathy","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116199_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114958","article-title":"Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway","volume":"164","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116199_b0410","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mus.26846","article-title":"Recombinant human insulin-like growth factor-1 therapy for 6 months improves growth but not motor function in boys with Duchenne muscular dystrophy","volume":"61","author":"Rutter","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bcp.2024.116199_b0415","doi-asserted-by":"crossref","unstructured":"V.E. Bianchi, V. Locatelli, L. Rizzi, Neurotrophic and Neuroregenerative Effects of GH\/IGF1, (2017) 1\u201325. https:\/\/doi.org\/10.3390\/ijms18112441.","DOI":"10.3390\/ijms18112441"},{"key":"10.1016\/j.bcp.2024.116199_b0420","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M116.764597","article-title":"Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactions","author":"Pham","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2024.116199_b0425","doi-asserted-by":"crossref","DOI":"10.1007\/s12017-017-8467-5","article-title":"Mutation in GNE downregulates peroxiredoxin IV altering ER redox homeostasis","author":"Chanana","year":"2017","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.bcp.2024.116199_b0430","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.18632\/oncotarget.7997","article-title":"Increased amyloid \u03b2-peptide uptake in skeletal muscle is induced by hyposialylation and may account for apoptosis in GNE myopathy","volume":"7","author":"Bosch-Morat\u00f3","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116199_b0435","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9191-5","article-title":"GNE myopathy and cell apoptosis: A comparative mutation analysis","author":"Singh","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2024.116199_b0440","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/10799893.2014.956755","article-title":"Survival-apoptosis associated signaling in GNE myopathy-cultured myoblasts","volume":"35","author":"Harazi","year":"2015","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.bcp.2024.116199_b0445","doi-asserted-by":"crossref","unstructured":"K.A. Patzel, T. Yardeni, E. Le Po\u00ebc-celic, P. Leoyklang, D.S. Alonzi, N. V Kukushkin, B. Xu, Y. Zhang, M. Sollogoub, Y. Bl\u00e9riot, W.A. Gahl, M. Huizing, D. Terry, NIH Public Access, 37 (2015) 297\u2013308. https:\/\/doi.org\/10.1007\/s10545-013-9655-6.Non-specific.","DOI":"10.1007\/s10545-013-9655-6"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:58:40Z","timestamp":1777384720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":89,"alternative-id":["S0006295224001825"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116199","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential small effector molecules restoring cellular defects due to sialic acid biosynthetic enzyme deficiency: Pathological relevance to GNE myopathy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116199"}}